AST
holds the exclusive license to the intellectual property and commercial rights
relating to TAMARS in the United States, Europe, Australia, Japan , and all
other countries of the World other than the United Kingdom and the Republic of
Ireland ., President of AST, stated, "Following
thousands of successful treatments with the TAMARS device in the United
Kingdom and Republic of Ireland, we are delighted to begin clinical trials of
the TAMARS treatment in the United States on patients who, until TAMARS, have
suffered with chronic back pain and received little or no relief.

Contact: Ross H.

hypermobility distributors

The non-invasive, visually discreet Bellacure treatment device is worn
against the skin and gives patients and physicians the ability to precisely
adjust the amount of pain-relieving force applied to the osteoarthritic knee . In fact, the Bellacure treatment
device cannot be seen under most clothes and is covered in a silky material to
avoid bunching under pant legs. Such statements are
subject to certain risks and uncertainties and actual results could differ
materially from expected results.

applied prevent

Sky Capital Holdings Announces Clinical Trial Approval for Advanced Spinal Technologies

pain iliac

bellacure.

device prevent

AST's intention is
to position the use of the instrument as a medical device. Patients with back pain for three months or longer are
eligible for the study.

relief sacro

"I think the
greatest achievement we've made with the Bellacure treatment device is how all
this technology is transparent and easy for the patient to use. The company disclaims,
however , any intent or obligation to update these forward-looking statements.

applied back

(http://www.
"Recent advancements in biomechanics, microelectronics, micromechanics and
the technical garment industry have enabled us to produce an arthritis
treatment device that is efficient and effective," said Sterling . These clinical
trials, while not required for the FDA approval, are a significant step
towards becoming a recognised orthodox medicine in the United States and will
provide the first independent , publishable documentation of the safety and
effectiveness of TAMARS treatments in patients suffering from chronic back
pain.

instability spine

com).ereleases.

disorders backs

backs distributors

206-762-3609
mcannon@bellacure.com

This release was issued through eReleases(TM). Mandell
Sky Capital Holdings, Ltd .

therapist musculoskeletal

The initiation of this clinical trial is a big step towards achieving that
status in the United States.

treat relieving

As a result, patients will experience knee
pain relief without feeling self-conscious. was founded by two longtime industry leaders in the field
of OA treatment.

diseases sacro

In any year, 15% - 20% of Americans and 25% - 45% of Europeans suffer
from back pain.
TAMARS has become the basis of a carefully designed therapeutic procedure
that results in the restoration of spinal flexibility and mobility, and
reducing or eliminating back pain.

treat spd

"

About Bellacure, Inc. For more information,
visit http://www.
It is widely acknowledged that, around the world, back pain and injury
spending is increasing.

hypermobility iliac

"Patients can now
experience drug-free osteoarthritis pain relief at home with a level of
precision and intensity never before available in orthopedics."
Another advantage of the device: its low profile. The device bears little
resemblance to bulky , cumbersome knee braces.

These forward-looking statements represent
the company's judgement as of the date of this release.

chairs distributors

For more information on Bellacure or the Bellacure osteoarthritis knee
treatment unit, visit http://www. The clinical trials conform to strict
United States FDA guidelines and will enroll thirty patients in one of three
clinical sites.

hypermobility belt

SEATTLE, The millions of patients suffering from
arthritic knee pain now have a new treatment option, thanks to Bellacure , Inc. The company, which specializes in the treatment of
arthritis, has just released a new patent -pending device shown in preliminary
studies to offer significant pain relief without the use of surgery or drugs.com.D.

applied diseases

Bellacure Inc. Releases Non-Invasive Treatment Device for Arthritic Knee Patients

"Most of the technology in the Bellacure treatment device is new to the
industry," explained Bellacure president Shane Sterling.com or call 800-795-2070. and LONDON, Sky
Holdings, listed on the AIM market of the London Stock Exchange, is pleased to
announce that its 18% owned investment , Advanced Spinal Technologies ("AST"),
has received approval from the Western Institutional Review Board to commence
clinical trials for its Technology-Assisted Micro-Mobilization and Reflex
Stimulator ("TAMARS") -- previously known as the pamm3 MicroManipulator."
Ross Mandell, CEO of Sky Holdings , commented, "From the first moment we
became involved with this incredible technology, it has been our intention
commercialise it on a world-wide scale and sell it as an orthodox medicine.
(212) 709-1900

Charles McLean
The Dilenschneider Group
(212) 922-0900

hypermobility applied

AST has already filed an application for marketing approval with the Food
+ Drug Administration ("FDA") of the United States Government seeking approval
for the use of the instrument, which is intended for adjustment, mobilization,
or manipulation of the musculoskeletal joints of the spine. Results will be evaluated on the Oswestry Low Back
Pain Disability Questionnaire, the Roland-Morris Low Back Pain and Disability
Questionnaire, the Hannover Activities of Daily Living Questionnaire, and the
Visual Analog Scale.

belt distributors

"
Statements in this press release other than statements of historical fact,
including statements regarding the company 's plans, beliefs, and estimates as
to projected market size are "forward-looking statements".

therapist disorders

Bellacure 's technology includes ultra soft, lightweight materials; unique
micro cables that match the device to the curve of the patient's leg; and a
dosimeter to provide patients with exactly the right decompressing force to
the arthritic compartment of the knee, delivering reliable pain relief every
time.com
http://www. Revolutionary New Back Treatment Heads for Clinical Trials

NEW YORK, BOCA RATON, Fla.

device iliac

Our goal is to
provide the arthritic pain relief patients need to seamlessly maintain or
return to their previous lifestyles.

Contact:

Mike Cannon
Bellacure, Inc. In the United States alone, where AST has the
exclusive license to the intellectual property and commercial rights for the
TAMARS instrument, Duke University researchers have demonstrated that $100
billion per annum is devoted to the care and relief of patients with back
pain. Jeffrey R.

aids disorders

Shane Sterling, a pioneer in the field of biomechanical
research and engineering, presides as president of the company, while
well-known orthopedic distribution manager and marketing director Mike Cannon
will take the helm as executive vice president in charge of sales and
marketing. Perelman , M.